The 10-second takeaway
For the quarter ended June 30 (Q2), Polypore International met expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue dropped and GAAP earnings per share dropped significantly.
Margins contracted across the board.
Polypore International recorded revenue of $185.8 million. The 12 analysts polled by S&P Capital IQ predicted sales of $185.7 million on the same basis. GAAP reported sales were 5.4% lower than the prior-year quarter's $196.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.51. The 10 earnings estimates compiled by S&P Capital IQ forecast $0.53 per share. GAAP EPS of $0.43 for Q2 were 32% lower than the prior-year quarter's $0.63 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 37.8%, 680 basis points worse than the prior-year quarter. Operating margin was 20.6%, 640 basis points worse than the prior-year quarter. Net margin was 11.0%, 400 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $203.5 million. On the bottom line, the average EPS estimate is $0.61.
Next year's average estimate for revenue is $790.9 million. The average EPS estimate is $2.38.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 235 members out of 259 rating the stock outperform, and 24 members rating it underperform. Among 55 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 49 give Polypore International a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Polypore International is outperform, with an average price target of $48.45.
Over the decades, small-cap stocks, like Polypore International have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Polypore International to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend Polypore International. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Polypore Sees Sales Sag As It Prepares for Its Breakup
The maker of membranes for the energy and healthcare industries reported flagging sales, but investors likely won't mind given its pending buyout.
Why Polypore International Stock Jumped 13% Today
Polypore International stock jumped on big news today. Here's what you need to know.
Why Polypore International Inc. Shares Plunged
Does this analyst make a good case? Or is it just more noise from Wall Street?